跳至主要内容
临床试验/CTRI/2019/05/019066
CTRI/2019/05/019066尚未招募2 期

A Randomized, Standard Controlled, Clinical Study to Evaluate the Safety and Efficacy of JawαÌ?rish Falafili in the Treatment of FartÌ£-e- Tadassum fiâ??l Dam (Dyslipidaemia) - PGD

Central Research Institute of Unani Medicine0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Participants of any sex aged 30-60 years.
  • Participants with having following lipid or lipoprotein abnormality
  • - Serum Cholesterol equal to or more than 200mg/dl.
  • - HDL-C less than 40 mg/dl
  • - LDL Cholesterol equal to or more than 130 mg/dl.
  • - Serum Triglycerides level equal to or more than
  • Both obese and non-obese.

排除标准

  • Participants aged less than 30 and more than 60 years.
  • Participants having a co-morbid condition like IHD, HT, Diabetes, etc.
  • Participants having a major systemic disorder which interferes in the
  • present study.
  • Pregnant or Lactating Women.
  • Significant Pulmonary/Cardiovascular/Hepato-renal Dysfunction
  • Known cases of Immunocompromised states (HIV/ AIDS,
  • etc.)/Malignancies
  • Participant not willing to attend treatment schedule regularly

研究者

相似试验

Clinical effectiveness of Unani drugs in comparison... | 临床试验